Phage therapy of Cronobacter-induced urinary tract infection in mice

Medical Science Monitor

Volumn 17, Issue 7, 2011, Pages

  Tóthová, Ľubomíra ^a   Celec, Peter ^a   Bábíčková, Janka ^a   Gajdošová, Jana ^a   Al Alami, Hend ^a   Kamodyová, Natália ^a   Drahovská, Hana ^a   Liptáková, Adriana ^a   Turňa, Ján ^a   Hodosy, Július ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Cronobacter spp.; Enterobacter sakazakii; Oxidative and carbonyl stress; Phage cocktail; Urinary tract infection

Indexed keywords

ADVANCED GLYCATION END PRODUCT; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIROTHERAPY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIUM CULTURE; BLADDER; COLONY FORMING UNIT; CONTROLLED STUDY; CRONOBACTER INFECTION; CRONOBACTER PHAGE; DRUG EFFICACY; ENTEROBACTER SAKAZAKII; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFECTION PREVENTION; KIDNEY; KIDNEY INFECTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TISSUE CULTURE; TISSUE LEVEL; URINARY TRACT INFECTION; VIROTHERAPY;

EID: 79959967665     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881844     Document Type: Article

References (34)

1. Lai KK: Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore), 2001; 80: 113-22
2. Bhat GK, Anandhi RS, Dhanya VC, Shenoy SM: Urinary tract infection due to Enterobacter sakazakii. Indian J Pathol Microbiol, 2009; 52: 430-31
3. Lehner A, Stephan R: Microbiological, epidemiological, and food safety aspects of Enterobacter sakazakii. J Food Prot, 2004; 67: 2850-57
4. Friedemann M: Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections. Eur J Clin Microbiol Infect Dis, 2009; 28: 1297-304
5. Stock I, Wiedemann B: Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect, 2002; 8: 564-78
6. Kurtaran B, Candevir A, Tasova Y et al: Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. Med Sci Monit, 2010; 16: CR246-CR251
7. Forsythe SJ: Enterobacter sakazakii and other bacteria in powdered infant milk formula. Matern Child Nutr, 2005; 1: 44-50
8. Iversen C, Lane M, Forsythe SJ: The growth profile, thermotolerance and biofilm formation of Enterobacter sakazakii grown in infant formula milk. Lett Appl Microbiol, 2004; 38: 378-82
9. Pagotto FJ, Nazarowec-White M, Bidawid S, Farber JM: Enterobacter sakazakii: infectivity and enterotoxin production in vitro and in vivo. J Food Prot, 2003; 66: 370-75
10. Kothary MH, McCardell BA, Frazar CD et al: Characterization of the zinc-containing metalloprotease encoded by zpx and development of a species-specific detection method for Enterobacter sakazakii. Appl Environ Microbiol, 2007; 73: 4142-51
11. Townsend S, Hurrell E, Forsythe S: Virulence studies of Enterobacter sakazakii isolates associated with a neonatal intensive care unit outbreak. BMC Microbiol, 2008; 8: 64
12. Kim K, Kim KP, Choi J et al: Outer membrane proteins A (OmpA) and X (OmpX) are essential for basolateral invasion of Cronobacter sakazakii. Appl Environ Microbiol, 2010; 76: 5188-98
13. Morel CM, Mossialos E: Stoking the antibiotic pipeline. BMJ, 2010; 340: c2115
14. O'Flaherty S, Ross RP, Coffey A: Bacteriophages and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev, 2009; 33: 801-19
15. Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Gorski A: Bacteriophage therapy in children: facts and prospects. Med Sci Monit, 2008; 14(8): RA126-RA132
16. Gorski A, Miedzybrodzki R, Borysowski J et al: Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs, 2009; 10: 766-74
17. Wright A, Hawkins CH, Anggard EE, Harper DR: A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol, 2009; 34: 349-57
18. Rhoads DD, Wolcott RD, Kuskowski MA et al: Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care, 2009; 18: 237-38, 340-43
19. Hagens S, Loessner MJ: Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Curr Pharm Biotechnol, 2010; 11: 58-68
20. Zuber S, Boissin-Delaporte C, Michot L et al: Decreasing Enterobacter sakazakii (Cronobacter spp.) food contamination level with bacteriophag-es: prospects and problems. Microb Biotechnol, 2008; 1: 532-43
21. Kim H, Ryu JH, Beuchat LR: Effectiveness of disinfectants in killing Enterobacter sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm. Appl Environ Microbiol, 2007; 73: 1256-65
22. Turcovsky I, Kunikova K, Drahovska H, Kaclikova E: Biochemical and molecular characterization of Cronobacter spp. (formerly Enterobacter sakazakii) isolated from foods. Antonie Van Leeuwenhoek, 2011; 99: 257-69
23. Hung CS, Dodson KW, Hultgren SJ: A murine model of urinary tract infection. Nat Protoc, 2009; 4: 1230-43
24. Munch G, Keis R, Wessels A et al: Determination of advanced glycation end products in serum by fuorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem, 1997; 35: 669-77
25. Ohkawa H, Ohishi N, Yagi K: Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J Lipid Res, 1978; 19: 1053-57
26. Erel O: A novel automated direct measurement method for total anti-oxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem, 2004; 37: 277-85
27. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976; 72: 248-54
28. Khorvash F, Mostafavizadeh K, Mobasherizadeh S, Behjati M: Susceptibility pattern of E. coli-associated urinary tract infection (UTI): a comparison of spinal cord injury-related and nosocomial UTI. Med Sci Monit, 2009; 15(11): CR579-CR82
29. Bernsmeier C, Nickel C, Bingisser R, Kim MJ: Urinary tract infection presenting with nonspecifc complaints and normal urinalysis in 84-year-old woman. Am J Case Rep, 2010; 11: 116-18
30. Yilmaz N, Agus N, Yurtsever SG et al: Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey. Med Sci Monit, 2009; 15(11): PI61-RI65
31. Wilke MH: Multiresistant bacteria and current therapy - the economical side of the story. Eur J Med Res, 2010; 15: 571-76
32. Kumari S, Harjai K, Chhibber S: Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol, 2011; 60: 205-10
33. Nishikawa H, Yasuda M, Uchiyama J et al: T-even-related bacteriophag-es as candidates for treatment of Escherichia coli urinary tract infections. Arch Virol, 2008; 153: 507-15
34. Przerwa A, Zimecki M, Switala-Jelen K et al: Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol, 2006; 195: 143-50